ANIP
ANIP
US00182C1036
ANI Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 883.366.000 614.376.000
43.8%
Cost of Revenue 341.310.000 250.210.000
36.4%
Gross Profit 542.056.000 364.166.000
48.8%
460.826.000 361.948.000
27.3%
Operating Income 81.230.000 2.218.000
3562.3%
Pretax Income 95.791.000 -22.212.000
531.3%
Net Income Common Stockholders 70.217.000 -20.147.000
448.5%
-- --
--
-- --
--
ende